Literature DB >> 12496446

CCR8 is not essential for the development of inflammation in a mouse model of allergic airway disease.

Chan D Chung1, Frederick Kuo, Jeffrey Kumer, Alykhan S Motani, Christopher E Lawrence, William R Henderson, Chandrasekar Venkataraman.   

Abstract

Chemokine receptors play an important role in the trafficking of various immune cell types to sites of inflammation. Several chemokine receptors are differentially expressed in Th1 and Th2 effector populations. Th2 cells selectively express CCR3, CCR4, and CCR8, which could direct their trafficking to sites of allergic inflammation. Additionally, increased expression of the CCR8 ligand, TCA-3, has been detected in affected lungs in a mouse model of asthma. In this study, CCR8-deficient mice were generated to address the biological role of CCR8 in a model of allergic airway disease. Using two different protocols of allergen challenge, we demonstrate that absence of CCR8 does not affect the development of pulmonary eosinophilia and Th2 cytokine responses. In addition, administration of anti-TCA-3-neutralizing Ab during allergen sensitization and rechallenge failed to inhibit airway allergic inflammation. These results suggest that CCR8 does not play an essential role in the pathogenesis of inflammation in this mouse model of allergic airway disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496446     DOI: 10.4049/jimmunol.170.1.581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.

Authors:  P C Rummel; K N Arfelt; L Baumann; T J Jenkins; S Thiele; H R Lüttichau; A Johnsen; J Pease; S Ghosh; R Kolbeck; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung.

Authors:  Cyrille Mionnet; Vanessa Buatois; Akira Kanda; Valerie Milcent; Sebastien Fleury; David Lair; Marie Langelot; Yannick Lacoeuille; Edith Hessel; Robert Coffman; Antoine Magnan; David Dombrowicz; Nicolas Glaichenhaus; Valerie Julia
Journal:  Nat Med       Date:  2010-10-31       Impact factor: 53.440

3.  iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity.

Authors:  Everett H Meyer; Marc-André Wurbel; Tracy L Staton; Muriel Pichavant; Matthew J Kan; Paul B Savage; Rosemarie H DeKruyff; Eugene C Butcher; James J Campbell; Dale T Umetsu
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

Review 4.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 5.  Chemokines and their receptors in the allergic airway inflammatory process.

Authors:  Juan Raymundo Velazquez; Luis Manuel Teran
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

6.  Dectin-2 regulates the effector phase of house dust mite-elicited pulmonary inflammation independently from its role in sensitization.

Authors:  Matthew W Parsons; Li Li; Aaron M Wallace; Min Jung Lee; Howard R Katz; James M Fernandez; Shinobu Saijo; Yoichiro Iwakura; K Frank Austen; Yoshihide Kanaoka; Nora A Barrett
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

7.  Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells.

Authors:  Jacky Y Suen; Brooke Gardiner; Sean Grimmond; David P Fairlie
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

8.  Expression of CCR8 is increased in asthma.

Authors:  K Mutalithas; C Guillen; C Raport; R Kolbeck; D Soler; C E Brightling; I D Pavord; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2010-04-28       Impact factor: 5.018

9.  CCR4 blockade does not inhibit allergic airways inflammation.

Authors:  Dolores M Conroy; Louise A Jopling; Clare M Lloyd; Martin R Hodge; David P Andrew; Timothy J Williams; James E Pease; Ian Sabroe
Journal:  J Leukoc Biol       Date:  2003-07-15       Impact factor: 4.962

10.  CD11b+ myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation.

Authors:  Benjamin D Medoff; Edward Seung; Sandra Hong; Seddon Y Thomas; Barry P Sandall; Jeremy S Duffield; Douglas A Kuperman; David J Erle; Andrew D Luster
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.